ClinicalMetric / Countries / Israel / neoplasm of stomach
← 🇮🇱 Israel Trials
🇮🇱 Israel Country × Condition

neoplasm of stomach Clinical Trials in Israel

Active clinical trials for neoplasm of stomach with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel

Active Trials in Israel (1)

NCT04519151 Phase 2
Recruiting

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Enrollment
24 pts
Country
🇮🇱 Israel
Sheba Medical Center
View Trial →

Frequently Asked Questions

How many neoplasm of stomach clinical trials are active in Israel?
There are currently 1 active clinical trials for neoplasm of stomach with sites in Israel, of which 1 are actively recruiting patients.
How can I join a neoplasm of stomach clinical trial in Israel?
To join a neoplasm of stomach clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are neoplasm of stomach trials in Israel?
Active neoplasm of stomach trials in Israel span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Israel Trials → Global neoplasm of stomach Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology